Abstract: Time Savings with Once-Monthly C.E.R.A.: A Time and Motion Study Conducted in 13 Hemodialysis Centres in Italy

 

Abstract: Time Savings with Once-Monthly C.E.R.A.: A Time and Motion Study Conducted in 13 Hemodialysis Centres in Italy

A major challenge for haemodialysis (HD) centres is to maximise efficiency in care provision while maintaining high standards of care. Our objective was to document health care professional (HCP) time for renal anaemia management for both shorter-acting erythropoiesis-stimulating agents (ESA) and Mircera, a continuous erythropoiesis receptor activator (C.E.R.A.) once monthly (Q4W), and model time savings with the use of Q4W C.E.R.A.